Arabkari V, Sultana A, Barua D, Webber M, Smith T, Gupta A, et al. UPR-Induced miR-616 Inhibits Human Breast Cancer Cell Growth and Migration by Targeting c-MYC. Int J Mol Sci. 2023;24: pubmed publisher

Li Y, Zhao Y, Yan X, Ye C, Weirich S, Zhang B, et al. CRL2ZER1/ZYG11B recognizes small N-terminal residues for degradation. Nat Commun. 2022;13:7636 pubmed publisher

Zhou J, Zhang B, Wang H, Wang D, Zhang M, Zhang M, et al. A Functional Screening Identifies a New Organic Selenium Compound Targeting Cancer Stem Cells: Role of c-Myc Transcription Activity Inhibition in Liver Cancer. Adv Sci (Weinh). 2022;9:e2201166 pubmed publisher

Damerell V, Ambele M, Salisbury S, Neumann Mufweba A, Durandt C, Pepper M, et al. The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells. Front Oncol. 2021;11:801691 pubmed publisher

Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, et al. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun. 2021;12:1940 pubmed publisher

Zhang B, Wang H, Zhao D, Wang D, Zeng Q, Xi J, et al. The splicing regulatory factor hnRNPU is a novel transcriptional target of c-Myc in hepatocellular carcinoma. FEBS Lett. 2021;595:68-84 pubmed publisher

Jing H, Hu J, He B, Negrón Abril Y, Stupinski J, Weiser K, et al. A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity. Cancer Cell. 2016;29:297-310 pubmed publisher